Sign Up to like & get recommendations! 0
Published in 2017 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2016.4792
Abstract: Importance Major adverse cardiovascular and cerebrovascular events (MACCE) are a significant source of perioperative morbidity and mortality following noncardiac surgery. Objective To evaluate national trends in perioperative cardiovascular outcomes and mortality after major noncardiac surgery… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.10046
Abstract: This comparative effectiveness research study investigates the association of order substitutions and education for the use of lactated Ringer solution with major adverse kidney events in an integrated health care system. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.34215
Abstract: Key Points Question What is the risk of major adverse cardiovascular events (MACEs) among patients with a prior intracerebral hemorrhage compared with the general population? Findings In this cohort study, 8991 patients with a prior… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "American journal of hematology"
DOI: 10.1002/ajh.26341
Abstract: Cardiovascular disease is a leading cause of death in survivors of immune-mediated thrombotic thrombocytopenic purpura (iTTP), but the epidemiology of major adverse cardiovascular events (MACE) in iTTP survivors is unknown. We evaluated the prevalence and… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26624
Abstract: To identify predictors of major adverse cardiovascular outcomes (MACE) among patients with prior percutaneous coronary intervention (PCI) who require noncardiac surgery. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23344
Abstract: There is a paucity of contemporary data assessing the implications of atrial fibrillation (AF) on major adverse cardiovascular events (MACE) in patients with or at high‐risk for atherosclerotic disease managed in routine practice. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical cardiology"
DOI: 10.1002/clc.23735
Abstract: BACKGROUND Arterial stiffness, as reflected in the cardio-ankle vascular index (CAVI), is a risk factor for major adverse cardiovascular events (MACEs). HYPOTHESIS Combining CAVI and metabolic syndrome (MetS) may enhance prediction of MACEs in a… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Clinical Cardiology"
DOI: 10.1002/clc.23989
Abstract: To examine the utility of fractional flow reserve by coronary computed tomography (CT) angiography (FFRCT) for predicting major adverse cardiovascular events (MACE) in patients with suspected coronary artery disease (CAD). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34348
Abstract: This is a retrospective cohort study by analyzing a multi‐institutional electronic medical records database in Taiwan to compare long‐term effectiveness and risk of major adverse cardiac events (MACE) in chemotherapy‐naïve metastatic castration‐resistant prostate cancer (mCRPC)… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.23220
Abstract: This study aimed at exploring the correlation of microRNA (miR)‐497/fibroblast growth factor‐23 (FGF‐23) axis with major adverse cardiac and cerebral event (MACCE) occurrence in end‐stage renal disease (ESRD) patients who underwent continuous ambulatory peritoneal dialysis… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Journal of Medical Systems"
DOI: 10.1007/s10916-017-0806-4
Abstract: Prediction of major adverse kidney events in critically ill patients may help target therapy, allow risk adjustment, and facilitate the conduct of clinical trials. In a cohort comprised of all critically ill adults admitted to… read more here.